NKCx Histopathological outcome* within 12 months after cervix cytology in 2021
231 Jönköping

  Benign LSIL HSIL AIS Cancer Other PAD missing Total
Cytologi Antal Andel Antal Andel Antal Andel Antal Andel Antal Andel Antal Andel Antal Andel Antal Andel
Benign sample 101 1.2% 25 0.3% 8 0.1% . . . . . . 8398 98.4% 8532 100.0%
ASCUS 275 28.0% 270 27.5% 112 11.4% 2 0.2% . . 5 0.5% 317 32.3% 981 100.0%
LSIL 62 20.7% 120 40.1% 57 19.1% 1 0.3% . . . . 59 19.7% 299 100.0%
Atypical glandular cells/AGC 1 12.5% 1 12.5% 1 12.5% 3 37.5% 1 12.5% . . 1 12.5% 8 100.0%
ASC-H 9 13.0% 16 23.2% 43 62.3% 1 1.4% . . . . . . 69 100.0%
HSIL 2 2.4% 13 15.3% 67 78.8% . . 1 1.2% 1 1.2% 1 1.2% 85 100.0%
Squamous cell cancer . . . . 1 100.0% . . . . . . . . 1 100.0%
Totalt 450 4.5% 445 4.5% 289 2.9% 7 0.1% 2 0.0% 6 0.1% 8776 88.0% 9975 100.0%

NOTE: Histopathological outcome from T83x taken into account.
This list includes only one diagnosis (the highest ranking) per person, applies to both Cyt and Pad.

* Harmonization of PAD codes classification between analysis registry and process registry has been carried out. PAD Class 0 (non diagnostic, unreasonable diagnosis) is excluded, and next PAD counts instead.
The classes 2a, b, c and 3a (suspected premalignant, pre-malignant UNS, HPV, suspected malignant) are grouped into 'Other'.
Process Registry's Class 1 (benign), 2d (LSIL) and 3b (manifest cancer) have all been introduced without exception. Some codes that occur beyond the scope of the process registry has been added to the different categories.
 

Snomed codes in the
category Cancer:
M80703, M81403